3P Biopharmaceuticals among the 100 best companies to work for in Spain

The prestigious ranking is based on an exhaustive questionnaire that Actualidad Económica prepares and publishes every year, and which seeks to evaluate and reward those companies whose human resources management makes them benchmarks.

3P Biopharmaceuticals (3P), a leading organization specializing in the development of cGMP processes and manufacturing of biological products (CDMO), has been selected as one of the 100 best companies to work for in Spain.

The prestigious ranking is based on an exhaustive questionnaire that Actualidad Económica prepares and publishes every year, and which seeks to evaluate and reward those companies whose human resources management makes them benchmarks. The assessment is based on 5 blocks that include talent management, development, remuneration and compensation, working environment, training and corporate social responsibility.

Aware that the human team is the key and differential factor for success in an international CDMO, one of 3P’s main priorities is the attraction and retention of talent in order to accompany its strategy and international expansion.

The company prioritises the development of talent, and is continuously promoting internal and external staff training and was awarded the Reconcilia seal for promoting business actions for the reconciliation of work, family and personal life.

3P Biopharmaceuticals among the 100 best companies to work for in Spain

“Both in attracting and retaining internal talent, at 3P we work to increase the value proposition we offer our employees, which translates into professional development opportunities, training (3P Campus), social benefits (flexible remuneration, benefits club, etc.), job stability, purpose of work and prioritisation of sustainability criteria (ESG), among others. We share a long-term vision of professional development and growth with our employees, where our first P is People”, says Tomas Alarcón, Human Resources Director at 3P.

In line with its commitment to the development of training and research in the field of biotechnology, 3P has signed an agreement with the Faculty of Pharmacy and Nutrition of the University of Navarra, which includes scholarships and prizes, to promote the training of students, both national and international in this field.

To conclude, it is worth highlighting the important renovation and expansion plan that the company is carrying out, which already includes the renovation of its rest areas, changing rooms and the modernisation of its meeting rooms. A reform carried out with the aim of improving the working conditions of its employees.

View the full press release here

Our dedicated team of specialists will be happy to discuss any of your CDMO supply chain needs. Contact us on +34 948 346 480 or email withinus@3pbio.com

Related Content

3P Biopharmaceuticals continues its successful collaboration with Toleranzia AB to fight Myasthenia Gravis.

Published: 19th September 2023
Toleranzia is at the forefront of innovation with their groundbreaking candidate, TOL2, designed to address the autoimmune neuromuscular disease, Myasthenia Gravis (MG).
Read more

3P Biopharmaceuticals lands in the United States.

Published: 8th June 2023
The Navarre biological CDMO inaugurates its first commercial office in Boston, supported by Keensight Capital.
Read more

3P Biopharmaceuticals continues its collaboration with U.S. biotech Zhittya for the treatment of Parkinson’s disease.

Published: 2nd May 2023
The process transfer and GMP supply of the FGF-1 candidate have been achieved successfully by both companies.
Read more

Get in touch

Let’s discuss your biologics journey.

Discover more about our people, our passion, and how we can work together to improve lives.